semaglutide effects on heart and cardiovascular outcomes in patients with obesity and prevalent failure: a prespecified analysis of the SELECT trial Benefits of Semaglutide GLP-1 Injections

Recent studies have shown that semaglutide, a GLP-1 receptor agonist, significantly aids in weight loss

Some researchers achieve their desired outcomes at 1.0mg or 1.7mg and stay there

Rarely, patients may experience palpitations or perceive the increased heart rate, though these symptoms usually do not require treatment discontinuation

To limit these gastrointestinal side effects, your GP or private healthcare provider will likely start you on a low dose of semaglutide and gradually increase your dose over time

Patients experiencing cold sensitivity whilst on GLP-1 therapy can implement several practical strategies to maintain comfort without discontinuing beneficial treatment